The present invention relates to sulfonyl compounds that interact with glucokinase regulatory protein. In addition, the present invention relates to methods of treating type 2 diabetes, and other diseases and/or conditions where glucokinase regulatory protein is involved using the compounds, or pharmaceutically acceptable salts thereof, and pharmaceutical compositions that contain the compounds, or pharmaceutically acceptable salts thereof.
本发明涉及与
葡萄糖激酶调节蛋白相互作用的磺酰基化合物。此外,本发明涉及使用这些化合物或其药学上可接受的盐治疗2型糖尿病和其他涉及
葡萄糖激酶调节蛋白的疾病和/或症状的方法,以及含有这些化合物或其药学上可接受的盐的药物组合物。